Abstract
We present a case illustrating how cerebral perfusion scintigraphy can be used to assist in crucial medical decision making in the intensive care setting for patients who are maintained on life support but are clinically suspected to have brain death. Cerebral perfusion scintigraphy can confirm brain death but cannot be used to diagnose it. 99mTc-HMPAO and 99mTc-ethylcysteinate dimer are the preferred imaging agents since they cross the blood–brain barrier.
Footnotes
Published online ▪▪▪.
